Събития за 05.04.2022

The genome of Cannabis sativa L. is about 900 Mb — 63 percent AT-rich and one-to-two percent polymorphic. Due to its size and repetitive nature, targeted sequencing approaches are desirable. Cannabinoids have been demonstrated to be therapeutic compounds, finding use in epilepsy, cancer, autoimmune disease, and even potentially in COVID-19. Understanding the genetics that govern the expression of these different compounds can assist in directed breeding efforts that maximize synthesis yield. The inheritance of cannabinoid expression in cannabis has been attributed to…